BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29676383)

  • 1. Leukemic conversion of hepatosplenic T-cell lymphoma with pleomorphic morphology and an aggressive course.
    Sharma P; Nampoothiri RV; Sharma P; Naseem S; Malhotra P; Varma N
    Indian J Pathol Microbiol; 2018; 61(2):292-293. PubMed ID: 29676383
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukemic phase of hepatosplenic T-cell lymphoma: A great masquerader of acute leukemia.
    Sharma S; Sreedharanunni S; Sachdeva MUS; Prakash G; Varma N
    Indian J Pathol Microbiol; 2017; 60(3):437-438. PubMed ID: 28937394
    [No Abstract]   [Full Text] [Related]  

  • 3. Histopathological, immunophenotypic and clinical particularities and evolution of a case of hepatosplenic T-cell lymphoma in transformation to leukemia.
    Benedek Lázár E; Köpeczi JB; Tunyogi AB; Kakucs E; Horváth E; Turcu M; Benedek I
    Rom J Morphol Embryol; 2013; 54(4):1135-9. PubMed ID: 24399013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?
    Ok CY; Yin CC; Yabe M; Bueso-Ramos CE; Miranda RN; Medeiros LJ; Konoplev SN
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e95-e100. PubMed ID: 24524924
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatosplenic T-cell lymphoma.
    te Boekhorst PA; van Lom K
    Br J Haematol; 2013 Nov; 163(4):422. PubMed ID: 24033076
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatosplenic T-cell lymphoma in a young immunocompetent man.
    Petrova M; Gomes MM; Carda JP; Pereira de Moura J
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer-Cell Neoplasms.
    Shi Y; Wang E
    Arch Pathol Lab Med; 2015 Sep; 139(9):1173-80. PubMed ID: 26317456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation.
    Steurer M; Stauder R; Grünewald K; Gunsilius E; Duba HC; Gastl G; Dirnhofer S
    Hum Pathol; 2002 Feb; 33(2):253-8. PubMed ID: 11957154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis.
    Yabe M; Medeiros LJ; Wang SA; Tang G; Bueso-Ramos CE; Jorgensen JL; Bhagat G; Chen W; Li S; Young KH; Miranda RN
    Am J Surg Pathol; 2017 Jan; 41(1):82-93. PubMed ID: 27755009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-18 Fluorodeoxyglucose non-avid hepatosplenic T cell lymphoma: a diagnostic pitfall.
    Ho SL; Loong F; Lam C; Anthony MP; Kwong YL
    Ann Hematol; 2012 Feb; 91(2):307-8. PubMed ID: 21584668
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastroenterology: Hepatosplenic T cell lymphoma associated with schistosomiasis.
    Azevedo P; Pedrosa MS; Resende V
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1333. PubMed ID: 26211690
    [No Abstract]   [Full Text] [Related]  

  • 12. NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis.
    Morice WG; Macon WR; Dogan A; Hanson CA; Kurtin PJ
    Leukemia; 2006 May; 20(5):883-6. PubMed ID: 16525496
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatosplenic T-Cell Lymphoma in an Immunocompetent Male with Central Nervous System Invasion: A Rare Clinical Entity.
    Wu F; Pan Y; Wang H; Tao Q; An F; Zhang J; Zhai Z
    Cytometry B Clin Cytom; 2019 Nov; 96(6):475-479. PubMed ID: 30500103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo CD3 negative hepatosplenic T-cell lymphoma: diagnostic challenges and pitfalls.
    Kapur LH; Khaled Y; Solh M; Ward D; Chang CC
    Arch Pathol Lab Med; 2014 Jul; 138(7):969-73. PubMed ID: 24978925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expect the unexpected - Loss of surface CD3 on flow cytometry in hepatosplenic T-cell lymphoma: An eye opener.
    Chauhan R; Tyagi S; Mirgh S; Mishra P; Seth T; Mahapatra M; Pati H; Saxena R
    Indian J Pathol Microbiol; 2018; 61(2):275-277. PubMed ID: 29676377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous presentation of hepatosplenic T-cell lymphoma-a potential mimicker of primary cutaneous gamma-delta T-cell lymphoma.
    Karpate A; Barcena C; Hohl D; Bisig B; de Leval L
    Virchows Arch; 2016 Nov; 469(5):591-596. PubMed ID: 27562705
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatosplenic lymphoma presenting initially as hemophagocytic syndrome in a 21-year-old man with Crohn's disease: a case report and literature review.
    Côté-Daigneault J; Bernard EJ
    Can J Gastroenterol; 2011 Aug; 25(8):417-8. PubMed ID: 21912765
    [No Abstract]   [Full Text] [Related]  

  • 18. Case report: a common presentation of a rare disease-hepatosplenic T-cell lymphoma.
    Munir J; Preston G; Polish R
    Hawaii Med J; 2004 Nov; 63(11):341-3. PubMed ID: 15633661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatosplenic T-cell lymphoma is a distinct rare entity: diagnosis by fine-needle aspiration cytology.
    Kumar R; Dey P; Das A; Sachdeva MS; Varma S
    Diagn Cytopathol; 2011 Sep; 39(9):677-80. PubMed ID: 21837655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatosplenic T-cell lymphoma: A case series.
    Ashmore P; Patel M; Vaughan J; Wiggill T; Willem P; van den Berg E; Philip V; Lakha A
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):78-84. PubMed ID: 25450840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.